Free Motion for Leave to File - District Court of Delaware - Delaware


File Size: 28.8 kB
Pages: 4
Date: September 8, 2008
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 686 Words, 4,392 Characters
Page Size: 614 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/37449/18.pdf

Download Motion for Leave to File - District Court of Delaware ( 28.8 kB)


Preview Motion for Leave to File - District Court of Delaware
Case 1 :06-cv-00741-SLR Document 18 Filed O1/22/2007 Page 1 of 2
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
)
CELGENE CORPORATION, NOVARTIS )
PHARMACEUTICALS CORPORATION and )
NOVARTIS PHARMA A.G., )
‘ )
Plaintiffs, )
v. ) Civil Action No. 06-741 (SLR)
)
ABRIKA PHARMACEUTICALS, INC., and )
ABRIKA LLLP, )
)
Defendants. )

DEFENDANTS’ MOTION FOR LEAVE TO FILE A
SUR-REPLY BRIEF OR, IN THE ALTERNATIVE, FOR ORAL ARGUMENT
Pursuant to Local Rule 7.l.2.(c), defendants Abrika Pharmaceuticals, Inc. and Abrika LLLP
("Abrika") respectfully request leave to file a short sur-reply brief to correct the record based on
subsequent developments and to address plaintiffs’ reliance, for the first time in their reply brief, on
unpublished orders entered in the Abbott Laboratories v. Andrx cases. Specifically, plaintiffs’
assertion that Abrika has not challenged jurisdiction in New Jersey, and may never do so, is
inaccurate. Abrika filed its motion to dismiss for lack of personal jurisdiction in New Jersey on
January 19, 2007, and expects to prevail on that motion. Further, plaintiffs’ argument that New
Jersey is a more convenient forum than Delaware is a red herring. Plaintiffs, not Abrika, chose to
sue in this forum. Abrika, moreover, does not, contest that plaintiffs may file a protective action.
Abrika simply argues, and the law makes clear, that plaintiffs cannot then be permitted to choose
which action will proceed.

Case 1:06-cv-00741-SLR Document 18 Filed O1/22/2007 Page 2 of 2
Alternatively, pursuant to Local Rule 7.1.4., Abrika submits that oral argument on
plaintiffs’ stay motion would narrow the issues for the Court and help clarify the interplay between
the Hatch-Waxman Act and plaintiffs’ "protective measure" claims.
CONCLUSION
For the foregoing reasons, defendants respectfully submit that the Court should grant
Abrika’s Motion for Leave to File a Sur-Reply Brief or, in the Alternative, for Oral Argument.
January 22, 2007 By: S [% ¢6’¢(,¢0 dre G. Bouchard ( ar No. 2054)
John M. Seaman (Bar No. 3868)
BOUCHARD MARGULES & FMEDLANDER, P.A.
222 Delaware Avenue, Suite 1400
Wilmington, DE 19801
Phone: (302) 573-3508
Fax: (302) 573-3501
OF COUNSEL:
James D. Veltrop (pro hac vice)
Jonathan A. Harris(pr0 hac vice)
Chad A. Landmon (pm hac vice)
J 0-Anne M. Kokoski (pro hac vice)
AXINN VELTROP & HARKRIDER LLP
90 State House Square
Hartford, CT 06103
Phone: (860) 275-8100
Fax: (860) 275-8101
2

Case 1:06-cv-00741-SLR Document 18-2 Filed 01/22/2007 Page 1 of 1
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
)
CELGENE CORPORATION, NOVARTIS )
PHARMACEUTICALS CORPORATION and )
NOVARTIS PHARMA A.G., )
)
Plaintiffs, )
v. ) Civil Action No. 06-74l (SLR)
)
ABRIKA PHARMACEUTICALS, INC., and )
ABRIKA LLLP, )
)
Defendants. )
)
ORDER GRANTING LEAVE TO FILE SUR-REPLY
Upon the motion of defendants Abrika Pharmaceuticals, Inc. and Abrika LLLP
("Abrika”) to file a sur-reply brief pursuant to Local Rule 7.1.2.(c),
IT IS HEREBY ORDERED this day of January, 2007, that Abrika’s
motion to file a sur-reply brief is hereby GRANTED.
United States District Judge

Case 1:06-cv-00741-SLR Document 18-3 Filed 01/22/2007 Page 1 of 1
CERTIFICATE OF SERVICE
I hereby certify that on this 22nd day of January, 2007, I caused to be served a
copy of the Defendants’ Motion for Leave to File a Sur-Reply Brief, or in the
Alternative, for Oral Argument upon the following counsel via CMHECF:
Philip A. Rovner, Esquire
Potter Anderson & Corroon
1313 N. Market Street
Wilmington, DE 19801
[email protected]
I further certify that on January 22, 2007, I caused copies of the foregoing
document to be served by e-mail on the above-listed counsel and on the following non-
registered participants.
Anthony M. Insogna, Esquire Robert L. Baechtold, Esquire
Lester J. Savit, Esquire Henry J. Renk, Esquire
JONES DAY Nicholas N. Kallas, Esquire
2750 High Bluff Drive, Suite 300 FITZPATRICK, CELLA HARPER & A
San Diego, CA 92130-2083 SCINTO
858.314.1200 30 Rockefeller Plaza
czmins0gna@j0nesday. com New York, NY 10112
[email protected] rbaechto/a'@fchs.c0m
[email protected] [email protected]
[email protected]
F. Dominic Cerrito, Esquire
JONES DAY
222 East 41s° Street
New York, New York 10017-6702
fdcerrit0@j0nesday. com
John M. Seaman ( 868)
{BMF-WOOS7664.}